{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T16:26:52Z","timestamp":1794500812176,"version":"4.9.1"},"reference-count":166,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Complementary Therapies in Medicine"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1016\/j.ctim.2020.102327","type":"journal-article","created":{"date-parts":[[2020,2,3]],"date-time":"2020-02-03T11:47:03Z","timestamp":1580730423000},"page":"102327","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":54,"special_numbering":"C","title":["Review\/overview of pain in sickle cell disease"],"prefix":"10.1016","volume":"49","author":[{"given":"Samir K.","family":"Ballas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepika S.","family":"Darbari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ctim.2020.102327_bib0005","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1001\/jama.1980.03310020019018","article-title":"Defining pain terms","volume":"244","author":"de Jong","year":"1980","journal-title":"JAMA"},{"key":"10.1016\/j.ctim.2020.102327_bib0010","first-page":"249","article-title":"Pain terms: list with definitions and notes on usage","volume":"6","author":"IASP","year":"1979","journal-title":"Pain"},{"key":"10.1016\/j.ctim.2020.102327_bib0015","first-page":"205","article-title":"Pain terms: a list with definitions and notes on usage","volume":"14","author":"IASP","year":"1982","journal-title":"Pain"},{"key":"10.1016\/j.ctim.2020.102327_bib0020","first-page":"37","article-title":"Development of a universal language of pain syndromes","volume":"Vol. 5","author":"Merskey","year":"1983"},{"key":"10.1016\/j.ctim.2020.102327_bib0025","series-title":"Sickle cell disease: basic principles and clinical practice","first-page":"745","article-title":"Neurobiology and treatment of pain","author":"Ballas","year":"1994"},{"issue":"12\u201315","key":"10.1016\/j.ctim.2020.102327_bib0030","first-page":"29","article-title":"Management of sickle cell disease","volume":"29","author":"Ballas","year":"1993","journal-title":"Hosp Physician"},{"key":"10.1016\/j.ctim.2020.102327_bib0035","series-title":"Conn\u2019s current therapy","first-page":"318","article-title":"Sickle cell disease","author":"Ballas","year":"1995"},{"key":"10.1016\/j.ctim.2020.102327_bib0040","series-title":"Current therapy of pain","first-page":"90","article-title":"Pain in sickle cell disease","author":"Benjamin","year":"1989"},{"key":"10.1016\/j.ctim.2020.102327_bib0045","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/j.1749-6632.1989.tb24166.x","article-title":"Pain management in sickle cell disease. Rationale and techniques","volume":"565","author":"Payne","year":"1989","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.ctim.2020.102327_bib0050","series-title":"Words from the myths","author":"Azimov","year":"1965"},{"issue":"10","key":"10.1016\/j.ctim.2020.102327_bib0055","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1093\/pm\/pnw074","article-title":"The opioid drug epidemic and sickle cell disease: guilt by association","volume":"17","author":"Ruta","year":"2016","journal-title":"Pain Med"},{"issue":"10","key":"10.1016\/j.ctim.2020.102327_bib0060","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1001\/jama.2014.10517","article-title":"Management of sickle cell disease: summary of the 2014 evidence-based report by expert panel members","volume":"312","author":"Yawn","year":"2014","journal-title":"JAMA"},{"issue":"11","key":"10.1016\/j.ctim.2020.102327_bib0065","doi-asserted-by":"crossref","first-page":"3745","DOI":"10.1172\/JCI43158","article-title":"Pain as a channelopathy","volume":"120","author":"Raouf","year":"2010","journal-title":"J Clin Invest"},{"issue":"2","key":"10.1016\/j.ctim.2020.102327_bib0070","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/ejh.12460","article-title":"Pathophysiology and principles of management of the many faces of the acute vaso-occlusive crisis in patients with sickle cell disease","volume":"95","author":"Ballas","year":"2015","journal-title":"Eur J Haematol"},{"issue":"May (2)","key":"10.1016\/j.ctim.2020.102327_bib0075","doi-asserted-by":"crossref","first-page":"55","DOI":"10.7599\/hmr.2011.31.2.55","article-title":"Clinical Application of \u03b12-\u03b4 Ligand","author":"Shim","year":"2011","journal-title":"Hanyang Med Rev"},{"issue":"23","key":"10.1016\/j.ctim.2020.102327_bib0080","doi-asserted-by":"crossref","first-page":"3982","DOI":"10.1182\/bloodadvances.2019000882","article-title":"End points for sickle cell disease clinical trials: patient-reported outcomes, pain, and the brain","volume":"3","author":"Farrell","year":"2019","journal-title":"Blood Adv"},{"key":"10.1016\/j.ctim.2020.102327_bib0085","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/1744-8069-8-82","article-title":"Expression of Nav1.7 in DRG neurons extends from peripheral terminals in the skin to central preterminal branches and terminals in the dorsal horn","volume":"8","author":"Black","year":"2012","journal-title":"Mol Pain"},{"issue":"8","key":"10.1016\/j.ctim.2020.102327_bib0090","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1517\/14728222.2016.1162295","article-title":"Nav1.7 and other voltage-gated sodium channels as drug targets for pain relief","volume":"20","author":"Emery","year":"2016","journal-title":"Expert Opin Ther Targets"},{"issue":"3","key":"10.1016\/j.ctim.2020.102327_bib0095","doi-asserted-by":"crossref","DOI":"10.3390\/toxins8030078","article-title":"Analgesic effects of GpTx-1, PF-04856264 and CNV1014802 in a mouse model of NaV1.7-mediated pain","volume":"8","author":"Deuis","year":"2016","journal-title":"Toxins"},{"issue":"3","key":"10.1016\/j.ctim.2020.102327_bib0100","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1097\/j.pain.0000000000001119","article-title":"NaV1.7 and pain: contribution of peripheral nerves","volume":"159","author":"Hoffmann","year":"2018","journal-title":"Pain"},{"key":"10.1016\/j.ctim.2020.102327_bib0105","series-title":"Department of Clinical and Experimental Epilepsy. Doctor of Philosophy","first-page":"286","article-title":"Alternative splicing in sodium channels: biophysical and functional effects in Nav1.1, Nav1.2 & Nav1.7","author":"Liavas","year":"2020"},{"key":"10.1016\/j.ctim.2020.102327_bib0110","series-title":"Pain","author":"Fields","year":"1987"},{"key":"10.1016\/j.ctim.2020.102327_bib0115","series-title":"Textbook of pain","author":"Wall","year":"1994"},{"issue":"7121","key":"10.1016\/j.ctim.2020.102327_bib0120","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1038\/nature05413","article-title":"An SCN9A channelopathy causes congenital inability to experience pain","volume":"444","author":"Cox","year":"2006","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.ctim.2020.102327_bib0125","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1136\/jmg.2003.012153","article-title":"Mutations in SCN9A, encoding a sodium channel alpha subunit, in patients with primary erythermalgia","volume":"41","author":"Yang","year":"2004","journal-title":"J Med Genet"},{"issue":"Pt 8","key":"10.1016\/j.ctim.2020.102327_bib0130","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1093\/brain\/awh514","article-title":"Gain-of-function mutation in Nav1.7 in familial erythromelalgia induces bursting of sensory neurons","volume":"128","author":"Dib-Hajj","year":"2005","journal-title":"Brain"},{"issue":"9","key":"10.1016\/j.ctim.2020.102327_bib0135","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/j.jpain.2009.06.012","article-title":"Central sensitization: a generator of pain hypersensitivity by central neural plasticity","volume":"10","author":"Latremoliere","year":"2009","journal-title":"J Pain"},{"issue":"5944","key":"10.1016\/j.ctim.2020.102327_bib0140","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1038\/306686a0","article-title":"Evidence for a central component of post-injury pain hypersensitivity","volume":"306","author":"Woolf","year":"1983","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.ctim.2020.102327_bib0145","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1093\/oxfordjournals.bmb.a072490","article-title":"Generation of acute pain: central mechanisms","volume":"47","author":"Woolf","year":"1991","journal-title":"Br Med Bull"},{"issue":"4","key":"10.1016\/j.ctim.2020.102327_bib0150","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1097\/01.anes.0000264769.87038.55","article-title":"Central sensitization: uncovering the relation between pain and plasticity","volume":"106","author":"Woolf","year":"2007","journal-title":"Anesthesiology"},{"key":"10.1016\/j.ctim.2020.102327_bib0155","series-title":"Harrison\u2019s principles of internal medicine","author":"Longo","year":"2012"},{"key":"10.1016\/j.ctim.2020.102327_bib0160","series-title":"Harrison\u2019s principles of internal medicine","first-page":"93","article-title":"Pain: pathophysiology and management","author":"Rathmell","year":"2012"},{"key":"10.1016\/j.ctim.2020.102327_bib0165","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.sjpain.2017.08.001","article-title":"Central sensitization associated with low fetal hemoglobin levels in adults with sickle cell anemia","volume":"17","author":"Darbari","year":"2017","journal-title":"Scand J Pain"},{"issue":"12","key":"10.1016\/j.ctim.2020.102327_bib0170","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1097\/AJP.0000000000000492","article-title":"Altered functional connectivity in sickle cell disease exists at rest and during acute pain challenge","volume":"33","author":"Zempsky","year":"2017","journal-title":"Clin J Pain"},{"issue":"11","key":"10.1016\/j.ctim.2020.102327_bib0175","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1016\/j.jpain.2015.07.005","article-title":"Frequency of hospitalizations for pain and association with altered brain network connectivity in sickle cell disease","volume":"16","author":"Darbari","year":"2015","journal-title":"J Pain"},{"issue":"6","key":"10.1016\/j.ctim.2020.102327_bib0180","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1097\/AJP.0b013e31816b2f43","article-title":"Opioid-induced hyperalgesia in humans: molecular mechanisms and clinical considerations","volume":"24","author":"Chu","year":"2008","journal-title":"Clin J Pain"},{"issue":"5723","key":"10.1016\/j.ctim.2020.102327_bib0185","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1126\/science.308.5723.778","article-title":"Neuroscience. The dark side of glia","volume":"308","author":"Miller","year":"2005","journal-title":"Science"},{"issue":"2\u20133","key":"10.1016\/j.ctim.2020.102327_bib0190","doi-asserted-by":"crossref","first-page":"105","DOI":"10.3233\/CH-189002","article-title":"Sickle cell disease: classification of clinical complications and approaches to preventive and therapeutic management","volume":"68","author":"Ballas","year":"2018","journal-title":"Clin Hemorheol Microcirc"},{"issue":"Jul(7)","key":"10.1016\/j.ctim.2020.102327_bib0195","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/j.jpain.2018.12.003","article-title":"Analgesic, anesthetic, and addiction clinical trial translations, innovations, opportunities, and networks-American Pain Society-American Academy of pain medicine pain taxonomy diagnostic criteria for acute sickle cell disease pain","volume":"20","author":"Field","year":"2019","journal-title":"J Pain"},{"issue":"1","key":"10.1016\/j.ctim.2020.102327_bib0200","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1080\/10739680802279394","article-title":"Sickle red cell-endothelium interactions","volume":"16","author":"Kaul","year":"2009","journal-title":"Microcirculation"},{"issue":"2","key":"10.1016\/j.ctim.2020.102327_bib0205","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.hoc.2013.11.006","article-title":"Inflammatory mediators of endothelial injury in sickle cell disease","volume":"28","author":"Hoppe","year":"2014","journal-title":"Hematol Oncol Clin North Am"},{"issue":"8","key":"10.1016\/j.ctim.2020.102327_bib0210","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1182\/blood.V79.8.2154.2154","article-title":"Red blood cell changes during the evolution of the sickle cell painful crisis","volume":"79","author":"Ballas","year":"1992","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.ctim.2020.102327_bib0215","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1111\/j.1365-2141.1992.tb02998.x","article-title":"Rheological changes in the prodromal and established phases of sickle cell vaso-occlusive crisis","volume":"81","author":"Akinola","year":"1992","journal-title":"Br J Haematol"},{"issue":"18","key":"10.1016\/j.ctim.2020.102327_bib0220","doi-asserted-by":"crossref","first-page":"3647","DOI":"10.1182\/blood-2012-04-383430","article-title":"Sickle cell pain: a critical reappraisal","volume":"120","author":"Ballas","year":"2012","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.ctim.2020.102327_bib0225","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1182\/blood.V86.2.776.bloodjournal862776","article-title":"Clinical events in the first decade in a cohort of infants with sickle cell disease. Cooperative Study of Sickle Cell Disease","volume":"86","author":"Gill","year":"1995","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.ctim.2020.102327_bib0230","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/pbc.24796","article-title":"Pain characteristics and age-related pain trajectories in infants and young children with sickle cell disease","volume":"61","author":"Dampier","year":"2014","journal-title":"Pediatr Blood Cancer"},{"issue":"7","key":"10.1016\/j.ctim.2020.102327_bib0235","first-page":"896","article-title":"Natural history and distribution of bone and bone marrow infarction in sickle hemoglobinopathies","volume":"43","author":"Kim","year":"2002","journal-title":"J Nucl Med"},{"issue":"2","key":"10.1016\/j.ctim.2020.102327_bib0240","doi-asserted-by":"crossref","first-page":"94","DOI":"10.7326\/0003-4819-148-2-200801150-00004","article-title":"Daily assessment of pain in adults with sickle cell disease","volume":"148","author":"Smith","year":"2008","journal-title":"Ann Intern Med"},{"issue":"May(5)","key":"10.1016\/j.ctim.2020.102327_bib0245","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.jpain.2016.12.016","article-title":"AAPT diagnostic criteria for chronic sickle cell disease pain","volume":"18","author":"Dampier","year":"2017","journal-title":"J Pain"},{"issue":"1","key":"10.1016\/j.ctim.2020.102327_bib0250","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJM199107043250103","article-title":"Pain in sickle cell disease. Rates and risk factors","volume":"325","author":"Platt","year":"1991","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.ctim.2020.102327_bib0255","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0079923","article-title":"Severe painful vaso-occlusive crises and mortality in a contemporary adult sickle cell anemia cohort study","volume":"8","author":"Darbari","year":"2013","journal-title":"PLoS One"},{"issue":"33","key":"10.1016\/j.ctim.2020.102327_bib0260","doi-asserted-by":"crossref","first-page":"11869","DOI":"10.1073\/pnas.0804799105","article-title":"DNA polymorphisms at the BCL11A, HBS1L-MYB, and beta-globin loci associate with fetal hemoglobin levels and pain crises in sickle cell disease","volume":"105","author":"Lettre","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"10.1016\/j.ctim.2020.102327_bib0265","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.jpeds.2011.07.018","article-title":"Markers of severe vaso-occlusive painful episode frequency in children and adolescents with sickle cell anemia","volume":"160","author":"Darbari","year":"2012","journal-title":"J Pediatr"},{"issue":"3","key":"10.1016\/j.ctim.2020.102327_bib0270","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1002\/ajh.2830480307","article-title":"Gender and haplotype effects upon hematological manifestations of adult sickle cell anemia","volume":"48","author":"Steinberg","year":"1995","journal-title":"Am J Hematol"},{"issue":"4","key":"10.1016\/j.ctim.2020.102327_bib0275","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1111\/j.1365-2141.2005.05411.x","article-title":"Predicting clinical severity in sickle cell anaemia","volume":"129","author":"Steinberg","year":"2005","journal-title":"Br J Haematol"},{"issue":"2","key":"10.1016\/j.ctim.2020.102327_bib0280","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1089\/jwh.2018.7147","article-title":"Acute vaso-occlusive pain is temporally associated with the onset of menstruation in women with sickle cell disease","volume":"28","author":"Sharma","year":"2019","journal-title":"J Womens Health (Larchmt)"},{"key":"10.1016\/j.ctim.2020.102327_bib0285","series-title":"Sickle cell pain","author":"Ballas","year":"2014"},{"issue":"3","key":"10.1016\/j.ctim.2020.102327_bib0290","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0022-3476(05)82156-0","article-title":"Cold water exposure and vaso-occlusive crises in sickle cell anemia","volume":"118","author":"Resar","year":"1991","journal-title":"J Pediatr"},{"issue":"21","key":"10.1016\/j.ctim.2020.102327_bib0295","doi-asserted-by":"crossref","first-page":"3216","DOI":"10.1182\/blood-2015-04-638288","article-title":"Pregnancy in sickle cell disease is at very high risk","volume":"125","author":"de Montalembert","year":"2015","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.ctim.2020.102327_bib0300","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1002\/(SICI)1096-8652(199703)54:3<183::AID-AJH2>3.0.CO;2-S","article-title":"Assessment of painful episode frequency in sickle-cell disease","volume":"54","author":"Westerman","year":"1997","journal-title":"Am J Hematol"},{"issue":"Jan(1)","key":"10.1016\/j.ctim.2020.102327_bib0305","doi-asserted-by":"crossref","first-page":"83","DOI":"10.3324\/haematol.2018.211391","article-title":"Mental stress causes vasoconstriction in sickle cell disease and normal controls","volume":"105","author":"Shah","year":"2020","journal-title":"Haematologica"},{"issue":"9","key":"10.1016\/j.ctim.2020.102327_bib0310","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1002\/ajh.25168","article-title":"Predictors of acute care utilization and acute pain treatment outcomes in adults with sickle cell disease: the role of non-hematologic characteristics and baseline chronic opioid dose","volume":"93","author":"Carroll","year":"2018","journal-title":"Am J Hematol"},{"issue":"5","key":"10.1016\/j.ctim.2020.102327_bib0315","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.jpain.2016.01.475","article-title":"An evaluation of central sensitization in patients with sickle cell disease","volume":"17","author":"Campbell","year":"2016","journal-title":"J Pain"},{"issue":"1","key":"10.1016\/j.ctim.2020.102327_bib0320","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1002\/ajh.21550","article-title":"Definitions of the phenotypic manifestations of sickle cell disease","volume":"85","author":"Ballas","year":"2010","journal-title":"Am J Hematol"},{"key":"10.1016\/j.ctim.2020.102327_bib0325","series-title":"Bonica\u2019s Management of Pain","first-page":"13","article-title":"Pain terms and taxonomies","author":"Turk","year":"2010"},{"key":"10.1016\/j.ctim.2020.102327_bib0330","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1097\/00007611-193410000-00003","article-title":"Pathology of sickle cell anemia","volume":"27","author":"Diggs","year":"1934","journal-title":"South Med J"},{"issue":"4","key":"10.1016\/j.ctim.2020.102327_bib0335","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1001\/archinte.1974.00320160184017","article-title":"Leg ulceration in sickle cell anemia","volume":"133","author":"Serjeant","year":"1974","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ctim.2020.102327_bib0340","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1182\/blood.V74.4.1403.1403","article-title":"Leg ulcers in patients in sickle cell disease","volume":"74","author":"Koshy","year":"1989","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.ctim.2020.102327_bib0345","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1159\/000204799","article-title":"Recombinant human erythropoietin induced rapid healing of a chronic leg ulcer in a patient with sickle cell disease","volume":"86","author":"al-Momen","year":"1991","journal-title":"Acta Haematol"},{"key":"10.1016\/j.ctim.2020.102327_bib0350","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7326\/0003-4819-88-1-1","article-title":"Natural history of sickle anemia in Saudi Arabs: a study of 270 subjects","volume":"88","author":"Perrine","year":"1978","journal-title":"Ann Intern Med"},{"issue":"12","key":"10.1016\/j.ctim.2020.102327_bib0355","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1136\/jcp.37.12.1321","article-title":"Sickle cell disease in Britain","volume":"37","author":"Brozovic","year":"1984","journal-title":"J Clin Pathol"},{"issue":"1","key":"10.1016\/j.ctim.2020.102327_bib0360","first-page":"3","article-title":"Complications of sickle cell disease in Benin City, Nigeria","volume":"65","author":"Adedeji","year":"1988","journal-title":"East Afr Med J"},{"issue":"1","key":"10.1016\/j.ctim.2020.102327_bib0365","first-page":"87","article-title":"Leg ulceration in sickle cell disease in Nigeria","volume":"31","author":"Akinyanju","year":"1979","journal-title":"Trop Geogr Med"},{"issue":"1","key":"10.1016\/j.ctim.2020.102327_bib0370","first-page":"11","article-title":"Chronic leg ulcers in sickle cell disease: experience in Ibadan, Nigeria","volume":"20","author":"Durosinmi","year":"1991","journal-title":"Afr J Med Med Sci"},{"key":"10.1016\/j.ctim.2020.102327_bib0375","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1001\/archinte.1974.00320160105009","article-title":"The sickle cell disease: clinical manifestations including the \u201csickle crisis\u201d","volume":"133","author":"Konotey-Ahulu","year":"1979","journal-title":"Arch Int Med"},{"key":"10.1016\/j.ctim.2020.102327_bib0380","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1097\/00043426-199023000-00022","article-title":"\u03b2s-Gene-cluster haplotypes in sickle cell anemia: clinical implications","volume":"12","author":"Powars","year":"1990","journal-title":"Am J Pediatr Hematol Oncol"},{"issue":"3","key":"10.1016\/j.ctim.2020.102327_bib0385","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1097\/00125817-200105000-00006","article-title":"Contribution of sickle cell disease to the occurrence of developmental disabilities: a population-based study","volume":"3","author":"Ashley-Koch","year":"2001","journal-title":"Genet Med"},{"issue":"5","key":"10.1016\/j.ctim.2020.102327_bib0390","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1111\/j.1365-2141.2006.06074.x","article-title":"Sickle cell leg ulcers: associations with haemolysis and SNPs in Klotho, TEK and genes of the TGF-beta\/BMP pathway","volume":"133","author":"Nolan","year":"2006","journal-title":"Br J Haematol"},{"issue":"1","key":"10.1016\/j.ctim.2020.102327_bib0395","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/ajh.24134","article-title":"Critical reviews: how we treat sickle cell patients with leg ulcers","volume":"91","author":"Minniti","year":"2016","journal-title":"Am J Hematol"},{"issue":"2","key":"10.1016\/j.ctim.2020.102327_bib0400","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1002\/ajh.2830360211","article-title":"Sickle cell anemia with few painful crises is characterized by decreased red cell deformability and increased number of dense cells","volume":"36","author":"Ballas","year":"1991","journal-title":"Am J Hematol"},{"key":"10.1016\/j.ctim.2020.102327_bib0405","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1056\/NEJM198005013021803","article-title":"Erythrocyte adherence to endothelium in sickle-cell anemia","volume":"302","author":"Hebbel","year":"1980","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ctim.2020.102327_bib0410","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1182\/blood.V78.10.2735.2735","article-title":"Relationship of clinical severity to packed red rheology in sickle cell anemia","volume":"78","author":"Phillips","year":"1991","journal-title":"Blood"},{"key":"10.1016\/j.ctim.2020.102327_bib0415","first-page":"51","article-title":"Immunity and leg ulcers in homozygous sickle cell disease","volume":"6","author":"Morgan","year":"1981","journal-title":"J Clin Lab Immunol"},{"issue":"6","key":"10.1016\/j.ctim.2020.102327_bib0420","doi-asserted-by":"crossref","first-page":"534","DOI":"10.7326\/0003-4819-111-6-534","article-title":"Antithrombin III concentrate for treatment of chronic leg ulcers in sickle cell-beta thalassemia: a pilot study","volume":"111","author":"Cacciola","year":"1989","journal-title":"Ann Intern Med"},{"issue":"2","key":"10.1016\/j.ctim.2020.102327_bib0425","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1042\/cs0920153","article-title":"Postural vasoconstriction and leg ulceration in homozygous sickle cell disease","volume":"92","author":"Mohan","year":"1997","journal-title":"Clin Sci (Lond, Engl: 1979)"},{"issue":"8","key":"10.1016\/j.ctim.2020.102327_bib0430","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1016\/j.biocel.2006.01.010","article-title":"Sickle cell disease and nitric oxide: a paradigm shift?","volume":"38","author":"Mack","year":"2006","journal-title":"Int J Biochem Cell Biol"},{"issue":"8","key":"10.1016\/j.ctim.2020.102327_bib0435","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1097\/00129334-200410000-00010","article-title":"Leg ulcers in sickle cell disease","volume":"17","author":"Trent","year":"2004","journal-title":"Adv Skin Wound Care"},{"issue":"5","key":"10.1016\/j.ctim.2020.102327_bib0440","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/j.hoc.2005.08.005","article-title":"Leg ulceration in sickle cell disease: medieval medicine in a modern world","volume":"19","author":"Serjeant","year":"2005","journal-title":"Hematol Oncol Clin North Am"},{"issue":"7","key":"10.1016\/j.ctim.2020.102327_bib0445","first-page":"366","article-title":"Sickle cell leg ulcers in Ghana","volume":"69","author":"Ankra-Badu","year":"1992","journal-title":"East Afr Med J"},{"issue":"7","key":"10.1016\/j.ctim.2020.102327_bib0450","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1001\/archinte.1987.00370070045007","article-title":"The painful crisis of homozygous sickle cell disease. A study of the risk factors","volume":"147","author":"Baum","year":"1987","journal-title":"Arch Intern Med"},{"issue":"1","key":"10.1016\/j.ctim.2020.102327_bib0455","doi-asserted-by":"crossref","first-page":"65","DOI":"10.5581\/1516-8484.20120018","article-title":"Low-level laser therapy of leg ulcer in sickle cell anemia","volume":"34","author":"Bonini-Domingos","year":"2012","journal-title":"Rev Bras Hematol Hemoter"},{"issue":"3","key":"10.1016\/j.ctim.2020.102327_bib0460","first-page":"121","article-title":"A randomized controlled trial of solcoseryl and duoderm in chronic sickle-cell ulcers","volume":"42","author":"La Grenade","year":"1993","journal-title":"West Indian Med J"},{"issue":"5","key":"10.1016\/j.ctim.2020.102327_bib0465","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1111\/j.1365-2141.2010.08395.x","article-title":"A randomized phase II trial of arginine butyrate with standard local therapy in refractory sickle cell leg ulcers","volume":"151","author":"McMahon","year":"2010","journal-title":"Br J Haematol"},{"issue":"8","key":"10.1016\/j.ctim.2020.102327_bib0470","first-page":"62","article-title":"Negative pressure therapy for complex wounds in patients with sickle-cell disease: a case study","volume":"56","author":"Oliveira Paggiaro","year":"2010","journal-title":"Ostomy Wound Manage"},{"key":"10.1016\/j.ctim.2020.102327_bib0475","series-title":"Sickle Cell Disease: Basic Principles and Clinical Practice","first-page":"681","article-title":"Leg ulcers and myofascial syndromes","author":"Phillips","year":"1994"},{"issue":"3 Pt 1","key":"10.1016\/j.ctim.2020.102327_bib0480","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S0190-9622(18)30758-8","article-title":"Propionyl-L-carnitine in chronic leg ulcers of homozygous sickle cell disease: a pilot study","volume":"37","author":"Serjeant","year":"1997","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"10.1016\/j.ctim.2020.102327_bib0485","first-page":"164","article-title":"Isoxsuprine hydrochloride in the therapy of sickle cell leg ulceration","volume":"26","author":"Serjeant","year":"1977","journal-title":"West Indian Med J"},{"key":"10.1016\/j.ctim.2020.102327_bib0490","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1182\/blood.V84.6.1775.1775","article-title":"The RGD study group","volume":"84","author":"Wethers","year":"1994","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.ctim.2020.102327_bib0495","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1111\/bjh.14326","article-title":"Autologous stem cell-based therapy for sickle cell leg ulcer: a pilot study","volume":"175","author":"Meneses","year":"2016","journal-title":"Br J Haematol"},{"issue":"2","key":"10.1016\/j.ctim.2020.102327_bib0500","doi-asserted-by":"crossref","first-page":"95","DOI":"10.3109\/03630269.2013.875476","article-title":"Leg amputation for an extensive, severe and intractable sickle cell anemia ulcer in a Brazilian patient","volume":"38","author":"Queiroz","year":"2014","journal-title":"Hemoglobin"},{"key":"10.1016\/j.ctim.2020.102327_bib0505","first-page":"267","article-title":"Natural history of sickle cell disease: the first ten years","volume":"12","author":"Powars","year":"1990","journal-title":"Semin Hematol"},{"issue":"3","key":"10.1016\/j.ctim.2020.102327_bib0510","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/0037-198X(87)90031-9","article-title":"Bone changes in the extremities in sickle cell anemia","volume":"22","author":"Bohrer","year":"1987","journal-title":"Semin Roentgenol"},{"issue":"4","key":"10.1016\/j.ctim.2020.102327_bib0515","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1111\/j.1365-2141.2005.05476.x","article-title":"Bone involvement in sickle cell disease","volume":"129","author":"Almeida","year":"2005","journal-title":"Br J Haematol"},{"issue":"21","key":"10.1016\/j.ctim.2020.102327_bib0520","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1056\/NEJM199111213252104","article-title":"Sickle cell disease as a cause of osteonecrosis of the femoral head","volume":"325","author":"Milner","year":"1991","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.ctim.2020.102327_bib0525","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.jbspin.2006.01.025","article-title":"Pathophysiology and natural history of avascular necrosis of bone","volume":"73","author":"Lafforgue","year":"2006","journal-title":"Joint Bone Spine"},{"issue":"7\u20138","key":"10.1016\/j.ctim.2020.102327_bib0530","doi-asserted-by":"crossref","first-page":"649","DOI":"10.3109\/03630268908998842","article-title":"The prevalence of avascular necrosis in sickle cell anemia: correlation with alpha-thalassemia","volume":"13","author":"Ballas","year":"1989","journal-title":"Hemoglobin"},{"issue":"15","key":"10.1016\/j.ctim.2020.102327_bib0535","doi-asserted-by":"crossref","first-page":"3054","DOI":"10.1182\/blood-2013-01-480277","article-title":"Does increased red blood cell deformability raise the risk for osteonecrosis in sickle cell anemia?","volume":"121","author":"Lemonne","year":"2013","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.ctim.2020.102327_bib0540","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1002\/(SICI)1096-8652(199606)52:2<103::AID-AJH6>3.0.CO;2-Y","article-title":"Core decompression in avascular necrosis of the hip in sickle-cell disease","volume":"52","author":"Styles","year":"1996","journal-title":"Am J Hematol"},{"issue":"12","key":"10.1016\/j.ctim.2020.102327_bib0545","doi-asserted-by":"crossref","first-page":"2573","DOI":"10.2106\/JBJS.E.01454","article-title":"Physical therapy alone compared with core decompression and physical therapy for femoral head osteonecrosis in sickle cell disease. Results of a multicenter study at a mean of three years after treatment","volume":"88","author":"Neumayr","year":"2006","journal-title":"J Bone Joint Surg Am"},{"issue":"244","key":"10.1016\/j.ctim.2020.102327_bib0550","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1097\/00003086-198907000-00019","article-title":"Long-term results of total hip arthroplasty for osteonecrosis of the femoral head. A comparison with osteoarthritis","author":"Saito","year":"1989","journal-title":"Clin Orthop Relat Res"},{"issue":"4","key":"10.1016\/j.ctim.2020.102327_bib0555","doi-asserted-by":"crossref","first-page":"499","DOI":"10.2106\/00004623-198870040-00004","article-title":"Osteonecrosis of the hip in the sickle-cell diseases. Treatment and complications","volume":"70","author":"Hanker","year":"1988","journal-title":"J Bone Joint Surg Am"},{"issue":"3","key":"10.1016\/j.ctim.2020.102327_bib0560","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1302\/0301-620X.71B3.2722941","article-title":"Total replacement of the hip for avascular necrosis in sickle cell disease","volume":"71","author":"Clarke","year":"1989","journal-title":"J Bone Joint Surg Br"},{"issue":"9597","key":"10.1016\/j.ctim.2020.102327_bib0565","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1016\/S0140-6736(07)60457-7","article-title":"The operation of the century: total hip replacement","volume":"370","author":"Learmonth","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.ctim.2020.102327_bib0570","doi-asserted-by":"crossref","DOI":"10.1100\/2012\/949535","article-title":"Beyond the definitions of the phenotypic complications of sickle cell disease: an update on management","volume":"2012","author":"Ballas","year":"2012","journal-title":"Scientific World J"},{"issue":"12","key":"10.1016\/j.ctim.2020.102327_bib0575","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1056\/NEJM198503213121206","article-title":"Bacterial arthritis","volume":"312","author":"Goldenberg","year":"1985","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.ctim.2020.102327_bib0580","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1007\/s11999-009-1149-3","article-title":"Septic arthritis in adults with sickle cell disease often is associated with osteomyelitis or osteonecrosis","volume":"468","author":"Hernigou","year":"2010","journal-title":"Clin Orthop Relat Res"},{"issue":"6","key":"10.1016\/j.ctim.2020.102327_bib0585","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1016\/S0033-8389(22)02293-X","article-title":"Osteomyelitis, acute and chronic","volume":"25","author":"David","year":"1987","journal-title":"Radiol Clin North Am"},{"issue":"3","key":"10.1016\/j.ctim.2020.102327_bib0590","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1034\/j.1600-0609.2000.90210.x","article-title":"Acute clinical events in 299 homozygous sickle cell patients living in France. French Study Group on Sickle Cell Disease","volume":"65","author":"Neonato","year":"2000","journal-title":"Eur J Haematol"},{"issue":"3","key":"10.1016\/j.ctim.2020.102327_bib0595","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/0049-0172(94)90076-0","article-title":"Salmonella osteomyelitis and arthritis in sickle cell disease","volume":"24","author":"Anand","year":"1994","journal-title":"Semin Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.ctim.2020.102327_bib0600","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1542\/peds.101.2.296","article-title":"Etiology of osteomyelitis complicating sickle cell disease","volume":"101","author":"Burnett","year":"1998","journal-title":"Pediatrics"},{"issue":"4","key":"10.1016\/j.ctim.2020.102327_bib0605","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1542\/peds.2004-2582","article-title":"Bone area and bone mineral content deficits in children with sickle cell disease","volume":"116","author":"Buison","year":"2005","journal-title":"Pediatrics"},{"issue":"4","key":"10.1016\/j.ctim.2020.102327_bib0610","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1002\/ajh.20541","article-title":"High prevalence and correlates of low bone mineral density in young adults with sickle cell disease","volume":"81","author":"Miller","year":"2006","journal-title":"Am J Hematol"},{"issue":"5","key":"10.1016\/j.ctim.2020.102327_bib0615","doi-asserted-by":"crossref","first-page":"193","DOI":"10.4103\/0019-5359.40984","article-title":"Secondary osteoporosis due to sickle cell anemia: do sex steroids play a role?","volume":"62","author":"Sadat-Ali","year":"2008","journal-title":"Indian J Med Sci"},{"issue":"4","key":"10.1016\/j.ctim.2020.102327_bib0620","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1111\/j.1365-2141.2006.06487.x","article-title":"Bone mass density in adults with sickle cell disease","volume":"136","author":"Sarrai","year":"2007","journal-title":"Br J Haematol"},{"issue":"2","key":"10.1016\/j.ctim.2020.102327_bib0625","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jocn.2009.05.010","article-title":"Morphometry of the thoracolumbar vertebrae in sickle cell disease","volume":"17","author":"Serarslan","year":"2010","journal-title":"J Clin Neurosci"},{"issue":"7","key":"10.1016\/j.ctim.2020.102327_bib0630","first-page":"980","article-title":"Influence of androgens on bone mass in young women with sickle cell anemia","volume":"29","author":"Al-Elq","year":"2008","journal-title":"Saudi Med J"},{"issue":"3","key":"10.1016\/j.ctim.2020.102327_bib0635","first-page":"169","article-title":"Influence of pregnancy on bone mass in sickle cell anemia","volume":"28","author":"Al-Turki","year":"2009","journal-title":"West Afr J Med"},{"issue":"5","key":"10.1016\/j.ctim.2020.102327_bib0640","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1590\/S1807-59322011000500015","article-title":"Low bone mass density is associated with hemolysis in Brazilian patients with sickle cell disease","volume":"66","author":"Baldanzi","year":"2011","journal-title":"Clinics (Sao Paulo, Brazil)"},{"issue":"4","key":"10.1016\/j.ctim.2020.102327_bib0645","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1093\/tropej\/44.4.194","article-title":"Decreased bone mineral density in prepubertal children with sickle cell disease: correlation with growth parameters, degree of siderosis and secretion of growth factors","volume":"44","author":"Soliman","year":"1998","journal-title":"J Trop Pediatr"},{"key":"10.1016\/j.ctim.2020.102327_bib0650","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.bone.2008.03.003","article-title":"Fracture prevalence and relationship to endocrinopathy in iron overloaded patients with sickle cell disease and thalassemia","volume":"43","author":"Fung","year":"2008","journal-title":"Bone"},{"issue":"8","key":"10.1016\/j.ctim.2020.102327_bib0655","first-page":"816","article-title":"Stress fracture of the femur: a rare complication of sickle cell disease","volume":"88","author":"Bahebeck","year":"2002","journal-title":"Rev Chir Orthop Reparatrice Appar Mot"},{"issue":"2","key":"10.1016\/j.ctim.2020.102327_bib0660","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1097\/01241398-198603000-00011","article-title":"Pathological fracture complicating long bone osteomyelitis in patients with sickle cell disease","volume":"6","author":"Ebong","year":"1986","journal-title":"J Pediatr Orthop"},{"issue":"1","key":"10.1016\/j.ctim.2020.102327_bib0665","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1179\/027249302125000148","article-title":"Sickle cell morbidity profile in Omani children","volume":"22","author":"Jaiyesimi","year":"2002","journal-title":"Ann Trop Paediatr"},{"issue":"9","key":"10.1016\/j.ctim.2020.102327_bib0670","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1111\/j.1537-2995.2008.01775.x","article-title":"Disparity in the management of iron overload between patients with sickle cell disease and thalassemia who received transfusions","volume":"48","author":"Fung","year":"2008","journal-title":"Transfusion"},{"issue":"11","key":"10.1016\/j.ctim.2020.102327_bib0675","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1136\/ard.45.11.911","article-title":"Acute osteomyelitis in Nigerians with sickle cell disease","volume":"45","author":"Ebong","year":"1986","journal-title":"Ann Rheum Dis"},{"issue":"12","key":"10.1016\/j.ctim.2020.102327_bib0680","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1007\/s00198-006-0172-4","article-title":"An estimate of the worldwide prevalence and disability associated with osteoporotic fractures","volume":"17","author":"Johnell","year":"2006","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.ctim.2020.102327_bib0685","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.pain.2012.09.008","article-title":"Resident glial cell activation in response to perispinal inflammation leads to acute changes in nociceptive sensitivity: implications for the generation of neuropathic pain","volume":"154","author":"Tenorio","year":"2013","journal-title":"Pain"},{"key":"10.1016\/j.ctim.2020.102327_bib0690","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1002\/j.1532-2149.2012.00219.x","article-title":"The contribution of satellite glial cells to chemotherapy-induced neuropathic pain","volume":"17","author":"Warwick","year":"2013","journal-title":"Eur J Pain"},{"issue":"11","key":"10.1016\/j.ctim.2020.102327_bib0695","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1002\/ajh.23575","article-title":"Neuropathy, neuropathic pain, and sickle cell disease","volume":"88","author":"Ballas","year":"2013","journal-title":"Am J Hematol"},{"issue":"7773","key":"10.1016\/j.ctim.2020.102327_bib0700","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/S0140-6736(72)91788-6","article-title":"Mental-nerve neuropathy: a complication of sickle-cell crisis","volume":"2","author":"Konotey-Ahulu","year":"1972","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.ctim.2020.102327_bib0705","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/0030-4220(79)90295-0","article-title":"Mental nerve paresthesia secondary to sickle-cell crisis","volume":"48","author":"Kirson","year":"1979","journal-title":"Oral Surg Oral Med Oral Pathol"},{"issue":"2","key":"10.1016\/j.ctim.2020.102327_bib0710","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1212\/WNL.30.2.210","article-title":"Multiple cranial neuropathies, trigeminal neuralgia, and vascular headaches in sickle cell disease, a possible common mechanism","volume":"30","author":"Asher","year":"1980","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.ctim.2020.102327_bib0715","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1002\/mus.880140412","article-title":"Mononeuropathy in sickle cell anemia: anatomical and pathophysiological basis for its rarity","volume":"14","author":"Shields","year":"1991","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.ctim.2020.102327_bib0720","first-page":"53","article-title":"Peripheral neuropathy in adults with sickle cell disease","volume":"71","author":"Ballas","year":"1997","journal-title":"Am J Pain Med."},{"issue":"3","key":"10.1016\/j.ctim.2020.102327_bib0725","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1111\/papr.12279","article-title":"Safety and utility of quantitative sensory testing among adults with sickle cell disease: indicators of neuropathic pain?","volume":"16","author":"Ezenwa","year":"2016","journal-title":"Pain Pract"},{"issue":"9","key":"10.1016\/j.ctim.2020.102327_bib0730","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1002\/pbc.25574","article-title":"Early insights into the neurobiology of pain in sickle cell disease: a systematic review of the literature","volume":"62","author":"Brandow","year":"2015","journal-title":"Pediatr Blood Cancer"},{"issue":"3","key":"10.1016\/j.ctim.2020.102327_bib0735","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1002\/pbc.24838","article-title":"Neuropathic pain in patients with sickle cell disease","volume":"61","author":"Brandow","year":"2014","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.ctim.2020.102327_bib0740","series-title":"Sickle cell disease: basic principles and clinical practice","first-page":"599","article-title":"Neurological complications","author":"Adams","year":"1994"},{"issue":"6","key":"10.1016\/j.ctim.2020.102327_bib0745","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.pmn.2017.07.003","article-title":"Management of sickle cell pain using pregabalin: a pilot study","volume":"18","author":"Schlaeger","year":"2017","journal-title":"Pain Manag Nurs"},{"key":"10.1016\/j.ctim.2020.102327_bib0750","series-title":"Pain comorbidities","first-page":"507","author":"Giamberardino","year":"2012"},{"issue":"23","key":"10.1016\/j.ctim.2020.102327_bib0755","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1056\/NEJM199406093302303","article-title":"Mortality in sickle cell disease. Life expectancy and risk factors for early death","volume":"330","author":"Platt","year":"1994","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.ctim.2020.102327_bib0760","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/ajh.21699","article-title":"The risks and benefits of long-term use of hydroxyurea in sickle cell anemia: a 17.5 year follow-up","volume":"85","author":"Steinberg","year":"2010","journal-title":"Am J Hematol"},{"issue":"9257","key":"10.1016\/j.ctim.2020.102327_bib0765","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/S0140-6736(00)04132-5","article-title":"Survival estimates for patients with homozygous sickle-cell disease in Jamaica: a clinic-based population study","volume":"357","author":"Wierenga","year":"2001","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.ctim.2020.102327_bib0770","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1002\/pbc.25608","article-title":"Survival among children and adults with sickle cell disease in Belgium: Benefit from hydroxyurea treatment","volume":"62","author":"Le","year":"2015","journal-title":"Pediatr Blood Cancer"},{"issue":"10","key":"10.1016\/j.ctim.2020.102327_bib0775","doi-asserted-by":"crossref","first-page":"3997","DOI":"10.1182\/blood.V86.10.3997.bloodjournal86103997","article-title":"Sickle cell anemia in septuagenarians","volume":"86","author":"Steinberg","year":"1995","journal-title":"Blood"},{"issue":"19","key":"10.1016\/j.ctim.2020.102327_bib0780","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.1182\/blood-2016-05-715946","article-title":"Case series of octogenarians with sickle cell disease","volume":"128","author":"Ballas","year":"2016","journal-title":"Blood"},{"issue":"2\u20133","key":"10.1016\/j.ctim.2020.102327_bib0785","doi-asserted-by":"crossref","first-page":"129","DOI":"10.3233\/CH-189003","article-title":"Comorbidities in aging patients with sickle cell disease","volume":"68","author":"Ballas","year":"2018","journal-title":"Clin Hemorheol Microcirc"},{"issue":"12","key":"10.1016\/j.ctim.2020.102327_bib0790","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1111\/j.2042-7158.1954.tb11033.x","article-title":"Synthetic analgesics: stereochemical considerations","volume":"6","author":"Beckett","year":"1954","journal-title":"J Pharm Pharmacol"},{"issue":"4644","key":"10.1016\/j.ctim.2020.102327_bib0795","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1126\/science.6322304","article-title":"Drug and neurotransmitter receptors in the brain","volume":"224","author":"Snyder","year":"1984","journal-title":"Science"},{"key":"10.1016\/j.ctim.2020.102327_bib0800","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1124\/mol.112.083279","article-title":"Recent developments in the study of opioid receptors","volume":"83","author":"Cox","year":"2013","journal-title":"Mol Pharmacol"},{"issue":"7398","key":"10.1016\/j.ctim.2020.102327_bib0805","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1038\/nature11111","article-title":"Structure of the delta-opioid receptor bound to naltrindole","volume":"485","author":"Granier","year":"2012","journal-title":"Nature"},{"issue":"7398","key":"10.1016\/j.ctim.2020.102327_bib0810","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/nature10954","article-title":"Crystal structure of the micro-opioid receptor bound to a morphinan antagonist","volume":"485","author":"Manglik","year":"2012","journal-title":"Nature"},{"issue":"7398","key":"10.1016\/j.ctim.2020.102327_bib0815","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1038\/nature11085","article-title":"Structure of the nociceptin\/orphanin FQ receptor in complex with a peptide mimetic","volume":"485","author":"Thompson","year":"2012","journal-title":"Nature"},{"issue":"7398","key":"10.1016\/j.ctim.2020.102327_bib0820","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/nature10939","article-title":"Structure of the human kappa-opioid receptor in complex with JDTic","volume":"485","author":"Wu","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.ctim.2020.102327_bib0825","series-title":"Sickle cell pain","first-page":"251","article-title":"Chapter 9: pharmacology of analgesics and adjuvant","author":"Ballas","year":"2014"},{"issue":"1","key":"10.1016\/j.ctim.2020.102327_bib0830","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1002\/ajh.2830340111","article-title":"Treatment of pain in adults with sickle cell disease","volume":"34","author":"Ballas","year":"1990","journal-title":"Am J Hematol"}],"container-title":["Complementary Therapies in Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0965229919307976?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0965229919307976?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T17:15:17Z","timestamp":1760807717000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0965229919307976"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":166,"alternative-id":["S0965229919307976"],"URL":"https:\/\/doi.org\/10.1016\/j.ctim.2020.102327","relation":{},"ISSN":["0965-2299"],"issn-type":[{"value":"0965-2299","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Review\/overview of pain in sickle cell disease","name":"articletitle","label":"Article Title"},{"value":"Complementary Therapies in Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctim.2020.102327","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"102327"}}